Latent Epstein Barr Virus (EBV) Causes Nasopharynx Cancer; polyDNA Reviews Scientific Studies - AZTV7/Cable 13, Me-TV 7.2, HSN 7.3, Phoenix-Prescott, AZ

Latent Epstein Barr Virus (EBV) Causes Nasopharynx Cancer; polyDNA Reviews Scientific Studies

Posted:

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE:

The use of targeted therapies against EBV as stand-alone treatments is being explored, according to a study published in the American Society of Oncologys Educational Book in 2014. (1) polyDNA reviews the study and recommends two natural EBV remedies.

Rochester, NY (PRWEB) June 24, 2014

The latent Epstein Barr Virus (EBV) is linked to many different cancers, including Nasopharyngeal (or nasopharynx) cancer (NPC). This type of cancer is one of the most common cancers that develop in the uppermost region of the throat behind the nose. Dr. Radha Raghupathy, MD and colleagues wrote that undifferentiated NPC is characterized by type II EBV latency where latent genes are expressed Latent membrane protein 1 (LMP1) is the major oncogene (cancer causing gene) of EBV (1).

Because of the link between latent EBV and NPC, some doctors now believe that targeting EBV, instead of radiotherapy (radiation therapy), may be the most effective treatment for NPC. The use of targeted therapies against EBV as stand-alone or adjunctive treatments is being explored. (1)

polyDNA recommends that people infected with EBV take Novirin or Gene-Eden-VIR against the virus. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against EBV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, individuals infected with the (EBV and other viruses)reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR. (2) The study authors also wrote that, We observed a statistically significant decrease in the severity, duration, and frequency of symptoms. (2)

Both products can be ordered online on the Novirin and Gene-Eden-VIR websites.

Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

Dr. Raghupathy further wrote that We are in an exciting era in the history of NPC. Basic scientific knowledge of EBV and NPC carcinogenesis is being rapidly translated into clinical practice. The development of EBV-based screening tools, EBV-directed therapies are on the horizon. (1)

This is very important since people with a chronic EBV infection face a poor outcome. In addition to NPC, they can also develop life-threatening complications including hemophagocytic lymphohistiocytosis (a condition that causes the immune system to attack the bodys own tissues), organ failure, and malignant lymphomas (other types of cancer). (See Pediatrics International, from April 2014) (3)

The Mayo Clinic says that It isn't clear why some people with all the risk factors (for NPV) never develop cancer, while others who have no apparent risk factors do. (See the Mayo Clinic, from September 8, 2012) (4)

Dr. Polanskys book provides an answer. EBV chronically infects about 95% of the adult population, with virus usually present in B cells in a latent stage. According to Dr. Polansky, and his book Microcompetition with Foreign DNA and the Origin of Chronic Disease, people develop cancer when the number of latent viruses passes a certain threshold. One of the reasons for an increase in the number of latent viruses is a weak immune system. The CBCD offers a free download of Dr. Polanskys book to those who are interested in reading it. It can be downloaded here: http://www.cbcd.net/Book.php. (See the CBCD) (5)

What standard treatments are available for EBV infections?

A few antiviral drugs are available that were shown to inhibit EBV replication in cell culture. These drugs include the acyclic nucleoside analogues aciclovir, ganciclovir, penciclovir, and their respective prodrugs valaciclovir, valganciclovir and famciclovir, the acyclic nucleotide analogues cidofovir and adefovir, and the pyrophosphate analogue foscarnet. However, clinical studies have shown that these drugs are mostly ineffective in humans. (2) There are also natural antiviral products that studies show to be safe and effective in reducing EBV symptoms. Two of these products are Novirin and Gene-Eden-VIR.

We recommend that individuals infected with EBV take Novirin or Gene-Eden-VIR. The formula of these natural products was designed to help the immune system target the latent Epstein Barr Virus. Mike Evans, polyDNA

Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality, more expensive ingredients. The Novirin and Gene-Eden-VIR formula was tested in two post-marketing clinical studies published in September 2013 and March 2014, respectively, in the peer reviewed medical journal Pharmacy & Pharmacology.

Interested individuals can view the two published studies here, http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.

Learn more about Novirin and EBV and Gene-Eden-VIR and EBV.

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Epstein-Barr Virus as a Paradigm in Nasopharyngeal Cancer: From Lab to Clinic. Published in 2014.
http://www.ncbi.nlm.nih.gov/pubmed/?term=Epstein-Barr+Virus+as+a+Paradigm+in+Nasopharyngeal+Cancer%3A+From+Lab+to+Clinic

(2) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013. http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php

(3) Current research on chronic active Epstein-Barr virus infection in Japan. Published in April 2014.
http://www.ncbi.nlm.nih.gov/pubmed/24528553

(4) MayoClinic.org - Diseases and Conditions
Nasopharyngeal Carcinoma. Updated in September 2012.
http://www.mayoclinic.org/diseases-conditions/nasopharyngeal-carcinoma/basics/causes/con-20025379

(5) Microcompetition with Foreign DNA and the Origin of Chronic Disease. 2003 CBCD
http://www.cbcd.net/Book.php

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Novirin, an antiviral natural remedy that helps the immune system kill latent viruses.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/06/prweb11965943.htm

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and AZ-TV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.